Skip to main content

Blog

PPMD Provides $400,000 in Funding to MyoGene Bio Through PPMD Venture Pathways Program to Support Development of Gene Editing Platform

...

Avidity Biosciences to be Acquired by Novartis

...

Italfarmaco Addresses Patient Deaths, DUVYZAT Safety Profile in Community Letter

...

Becker Muscular Dystrophy Series Part 1: Neuromuscular Care and Genetics

...

20th Annual Sam’s Night Event Marks Two Decades of Community Impact, Growth, and Hope for Families Living with Duchenne

...

Newly Published Study Evaluates Patients’ and Caregivers’ Acceptable Risk from Gene Therapy

...

Avidity Biosciences Announces Positive Pre-BLA Meeting with FDA for del-zota

...

Standing Together for Access: Ensuring Duchenne Patients Can Benefit from Approved Therapies

...

Catch Up on World Muscle Society 2025

...

Building Protection: Vaccines and Dystrophinopathy

...